SG&A Expense (TTM) Chart

View SG&A Expense (TTM) for PEN.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View SG&A Expense (TTM) Chart
Start Trial

Historical SG&A Expense (TTM) Data

View and export this data back to 2014. Start Trial.
Date Value
June 30, 2026 741.31M
March 31, 2026 702.76M
December 31, 2025 663.42M
September 30, 2025 630.26M
June 30, 2025 601.09M
March 31, 2025 583.03M
December 31, 2024 573.99M
September 30, 2024 556.07M
June 30, 2024 542.26M
March 31, 2024 527.79M
December 31, 2023 506.45M
September 30, 2023 492.06M
June 30, 2023 474.72M
March 31, 2023 461.90M
December 31, 2022 449.72M
September 30, 2022 447.59M
June 30, 2022 433.41M
March 31, 2022 409.43M
December 31, 2021 378.33M
September 30, 2021 341.43M
June 30, 2021 323.20M
March 31, 2021 292.41M
December 31, 2020 287.07M
September 30, 2020 285.15M
Date Value
June 30, 2020 278.28M
March 31, 2020 286.10M
December 31, 2019 272.73M
September 30, 2019 259.22M
June 30, 2019 245.87M
March 31, 2019 232.98M
December 31, 2018 226.38M
September 30, 2018 216.68M
June 30, 2018 206.71M
March 31, 2018 196.09M
December 31, 2017 184.32M
September 30, 2017 174.46M
June 30, 2017 166.24M
March 31, 2017 157.96M
December 31, 2016 148.30M
September 30, 2016 135.84M
June 30, 2016 124.85M
March 31, 2016 115.37M
December 31, 2015 101.85M
September 30, 2015 88.79M
June 30, 2015 74.18M
March 31, 2015 47.79M
June 30, 2014 28.24M
March 31, 2014 12.15M

SG&A Expense (TTM) Range, Past 5 Years

View SG&A Expense (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

SG&A Expense (TTM) Benchmarks

View SG&A Expense (TTM) Benchmarks
Start Trial
Boston Scientific Corp. 7.159B
Globus Medical, Inc. 1.217B
Teleflex, Inc. 943.66M
Abbott Laboratories 13.94B
AngioDynamics, Inc. 157.09M